CBIO Catalyst Biosciences, Inc. gains 21% Jan 30, 2018

Posted By: Rajesh Srivastava - Tuesday, January 30, 2018

Share

& Comment

Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. http://www.priceseries.com/trade/CBIO-Catalyst-Biosciences-Inc--stock-gains-21-percent-a-Trade-Record-by-priceSeries-2018011720180130.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.